×

Baxter Operating Margin 2010-2024 | BAX

Current and historical operating margin for Baxter (BAX) over the last 10 years. The current operating profit margin for Baxter as of December 31, 2024 is 10.32%.
Baxter Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $10.64B $0.01B 0.13%
2024-09-30 $10.64B $0.57B 5.32%
2024-06-30 $10.54B $0.59B 5.60%
2024-03-31 $10.44B $0.77B 7.33%
2023-12-31 $10.36B $0.71B 6.82%
2023-09-30 $8.97B $-0.10B -1.13%
2023-06-30 $9.98B $-3.16B -31.68%
2023-03-31 $9.86B $-2.88B -29.19%
2022-12-31 $10.06B $-2.85B -28.29%
2022-09-30 $13.79B $-2.43B -17.63%
2022-06-30 $13.40B $0.96B 7.18%
2022-03-31 $12.91B $1.12B 8.70%
2021-12-31 $12.15B $1.35B 11.11%
2021-09-30 $12.45B $1.73B 13.92%
2021-06-30 $12.20B $1.69B 13.86%
2021-03-31 $11.82B $1.60B 13.51%
2020-12-31 $11.67B $1.62B 13.84%
2020-09-30 $11.53B $1.75B 15.14%
2020-06-30 $11.41B $1.78B 15.59%
2020-03-31 $11.53B $1.80B 15.60%
2019-12-31 $11.36B $1.77B 15.60%
2019-09-30 $11.14B $1.62B 14.56%
2019-06-30 $11.05B $1.50B 13.58%
2019-03-31 $11.06B $1.54B 13.88%
2018-12-31 $11.10B $1.58B 14.27%
2018-09-30 $11.08B $1.49B 13.42%
2018-06-30 $11.02B $1.40B 12.74%
2018-03-31 $10.79B $1.37B 12.67%
2017-12-31 $10.58B $1.29B 12.17%
2017-09-30 $10.43B $1.30B 12.49%
2017-06-30 $10.28B $1.19B 11.56%
2017-03-31 $10.26B $0.91B 8.87%
2016-12-31 $10.16B $0.75B 7.33%
2016-09-30 $10.12B $0.62B 6.13%
2016-06-30 $10.05B $0.53B 5.23%
2016-03-31 $9.94B $0.55B 5.48%
2015-12-31 $9.97B $0.45B 4.50%
2015-09-30 $10.15B $0.46B 4.55%
2015-06-30 $10.38B $0.59B 5.66%
2015-03-31 $12.06B $1.16B 9.61%
2014-12-31 $13.50B $1.74B 12.88%
2014-09-30 $15.03B $2.09B 13.93%
2014-06-30 $16.03B $2.53B 15.79%
2014-03-31 $15.55B $2.70B 17.36%
2013-12-31 $15.15B $2.74B 18.11%
2013-09-30 $14.33B $2.72B 18.99%
2013-06-30 $14.09B $2.84B 20.17%
2013-03-31 $14.00B $2.79B 19.95%
2012-12-31 $13.94B $2.77B 19.88%
2012-09-30 $14.03B $2.87B 20.47%
2012-06-30 $14.03B $2.84B 20.24%
2012-03-31 $14.00B $2.89B 20.68%
2011-12-31 $13.89B $2.95B 21.20%
2011-09-30 $13.80B $2.84B 20.61%
2011-06-30 $13.54B $2.88B 21.27%
2011-03-31 $13.20B $2.75B 20.82%
2010-12-31 $12.84B $2.14B 16.63%
2010-09-30 $12.82B $2.35B 18.31%
2010-06-30 $12.74B $2.30B 18.03%
2010-03-31 $12.67B $2.35B 18.52%
2009-12-31 $12.56B $2.88B 22.90%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.948B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.047B 28.90
Boston Scientific (BSX) United States $154.056B 41.59
Stryker (SYK) United States $148.022B 31.82
EssilorLuxottica (ESLOY) France $137.298B 0.00
Medtronic (MDT) Ireland $115.624B 16.89
Lonza Group Ag (LZAGY) Switzerland $46.792B 0.00
Haleon (HLN) United Kingdom $45.950B 29.85
GE HealthCare Technologies (GEHC) United States $41.418B 20.17
Agilent Technologies (A) United States $38.594B 25.57
ResMed (RMD) United States $33.728B 25.98
Terumo (TRUMY) Japan $25.984B 36.95
Koninklijke Philips (PHG) Netherlands $24.420B 17.44
Zimmer Biomet Holdings (ZBH) United States $21.098B 13.25
Insulet (PODD) United States $19.908B 85.13
Smith & Nephew SNATS (SNN) United Kingdom $11.490B 0.00
Sunny Optical Technology (SNPTF) China $11.331B 0.00
BellRing Brands (BRBR) United States $9.348B 35.03
Demant (WILYY) Denmark $8.092B 0.00
Bio-Rad Laboratories (BIO) United States $7.847B 27.17
Lantheus Holdings (LNTH) United States $5.489B 12.75
Prestige Consumer Healthcare (PBH) United States $4.215B 20.11
ICU Medical (ICUI) United States $3.924B 37.35
Envista Holdings (NVST) United States $3.683B 29.30
Perrigo (PRGO) Ireland $3.443B 10.14
Haemonetics (HAE) United States $3.312B 15.58
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.850B 19.20
QuidelOrtho (QDEL) United States $2.822B 23.71
LeMaitre Vascular (LMAT) United States $2.294B 55.75
Neogen (NEOG) United States $2.261B 26.05
AtriCure (ATRC) United States $1.916B 0.00
Green Thumb Industries (GTBIF) United States $1.494B 26.06
InMode (INMD) Israel $1.330B 11.12
BioLife Solutions (BLFS) United States $1.193B 0.00
AdaptHealth (AHCO) United States $1.150B 8.22
Maravai LifeSciences Holdings (MRVI) United States $1.013B 0.00
Curaleaf Holdings (CURLF) Canada $0.920B 0.00
CeriBell (CBLL) United States $0.911B 0.00
Phibro Animal Health (PAHC) United States $0.896B 13.74
Evolus (EOLS) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.657B 0.00
Valneva SE (VALN) France $0.635B 0.00
VAREX IMAGING (VREX) United States $0.538B 23.32
Omeros (OMER) United States $0.503B 0.00
Surmodics (SRDX) United States $0.501B 0.00
Owens & Minor (OMI) United States $0.493B 3.85
SNDL (SNDL) Canada $0.439B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
ZimVie (ZIMV) United States $0.368B 30.98
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.349B 0.00
Quanterix (QTRX) United States $0.311B 0.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Aurora Cannabis (ACB) Canada $0.308B 56.10
Cerus (CERS) United States $0.305B 0.00
Viemed Healthcare (VMD) United States $0.300B 28.52
OraSure Technologies (OSUR) United States $0.298B 19.95
Biote (BTMD) United States $0.252B 5.52
Canopy Growth (CGC) Canada $0.252B 0.00
Zynex (ZYXI) United States $0.234B 49.07
Sanuwave Health (SNWV) United States $0.231B 3.24
High Tide (HITI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.204B 15.21
Brainsway (BWAY) Israel $0.184B 97.80
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
MacroGenics (MGNX) United States $0.166B 0.00
TerrAscend (TSNDF) Canada $0.164B 0.00
Organigram Holdings (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.137B 17.17
Jin Medical (ZJYL) China $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.092B 12.92
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.083B 0.00
InterCure (INCR) Israel $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.069B 0.00
Exagen (XGN) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.057B 29.17
Apyx Medical (APYX) United States $0.054B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.046B 13.24
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.042B 0.00
INLIF (INLF) $0.032B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Allurion Technologies (ALUR) United States $0.009B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00